Atria Wealth Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,582
| Closed | -$1M | – | 1813 |
|
|
2025
Q1 | $1M | Sell |
1,582
-152
| -9% | -$96.4K | 0.01% | 892 |
|
|
2024
Q4 | $1.23M | Buy |
1,734
+93
| +6% | +$66.2K | 0.01% | 839 |
|
|
2024
Q3 | $1.73M | Sell |
1,641
-317
| -16% | -$333K | 0.02% | 688 |
|
|
2024
Q2 | $2.06M | Sell |
1,958
-22
| -1% | -$23.1K | 0.02% | 613 |
|
|
2024
Q1 | $1.91M | Buy |
1,980
+9
| +0.5% | +$8.66K | 0.02% | 659 |
|
|
2023
Q4 | $1.73M | Buy |
1,971
+218
| +12% | +$191K | 0.02% | 647 |
|
|
2023
Q3 | $1.44M | Sell |
1,753
-28
| -2% | -$23K | 0.02% | 672 |
|
|
2023
Q2 | $1.28M | Sell |
1,781
-298
| -14% | -$214K | 0.02% | 737 |
|
|
2023
Q1 | $1.71M | Buy |
2,079
+397
| +24% | +$326K | 0.03% | 592 |
|
|
2022
Q4 | $1.21M | Buy |
1,682
+216
| +15% | +$156K | 0.02% | 671 |
|
|
2022
Q3 | $1.01M | Sell |
1,466
-38
| -3% | -$26.2K | 0.02% | 705 |
|
|
2022
Q2 | $889K | Sell |
1,504
-194
| -11% | -$115K | 0.02% | 724 |
|
|
2022
Q1 | $1.19M | Buy |
+1,698
| New | +$1.19M | 0.02% | 664 |
|